Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 13/20 | 0.58 |
| ▸ | IL1RN | P18510 | 1/20 | 0.58 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.58 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.56 |
| ▸ | CCKAR | P32238 | 1/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30051361 | 0.90 | ACE (0.62) | ERAP2 | |
| SCHEMBL30052446 | 0.88 | ACE (0.59) | ERAP2 | |
| SCHEMBL31240179 | 0.87 | ERAP2 (0.62) | CCKBRIL1RNERAP2OPRD1CCKAR | |
| SCHEMBL30173378 | 0.87 | CTSC (0.62) | IL1RNERAP2OPRD1OPRM1 | |
| SCHEMBL29794116 | 0.87 | BACE1 (0.49) | — | |
| SCHEMBL31206898 | 0.86 | OPRM1 (0.60) | CCKBRIL1RNERAP2OPRD1CCKAR | |
| SCHEMBL29993798 | 0.85 | OPRD1 (0.65) | CCKBRIL1RNERAP2OPRD1CCKAR | |
| SCHEMBL30051739 | 0.84 | ACE (0.67) | ERAP2 | |
| SCHEMBL30052892 | 0.84 | ACE (0.67) | ERAP2 | |
| SCHEMBL30051858 | 0.84 | ACE (0.69) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4648788-A1 | LIPID BINDING PROTEIN MOLECULE THERAPY | Abionyx Pharma SA (FR) | 2025-11-19 | — | — | EP | disclosed |
| WO-2024150064-A9 | LIPID BINDING PROTEIN MOLECULE THERAPY | ABIONYX PHARMA SA (FR) | 2025-02-20 | — | — | WO | disclosed |
| WO-2024150064-A1 | LIPID BINDING PROTEIN MOLECULE THERAPY | ABIONYX PHARMA SA (FR) | 2024-07-18 | — | — | WO | disclosed |
| CN-116194148-A | Therapeutic combinations of GalNAc-oligonucleotide conjugates and saponins and uses thereof | 萨普雷米科技有限公司 | 2023-05-30 | — | — | CN | disclosed |